| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |